0 items USD 0.00Search
Your search for "mp advisors prioritizing generic drug development pipeline top fifty opportunities" gave back 35376 results.
Diabetes has emerged as a major economic burden with high associated human and financial cost. It a chronic disease affecting millions of population...
Catalog:
Rockville Research
March 2017
Price: USD 1,100.00
Respiratory diseases refers to pathological condition affecting lungs and other parts of the respiratory system. Asthma and COPD are the two most...
Catalog:
Rockville Research
May 2019
Price: USD 1,100.00
Pharmaceuticals in Turkey - Market Summary, Competitive Analysis and Forecast, 2016-2025 Summary Pharmaceuticals in Turkey industry profile provides...
Catalog:
MarketLine
July 2021
Price: USD 350.00
Eyes are one of the most vital sensory organs and is second most complex after brain. It is a vulnerable organ with various disorders that can...
Catalog:
Rockville Research
May 2019
Price: USD 1,100.00
Avon Products Inc - Strategy, SWOT and Corporate Finance Report Summary Avon Products Inc - Strategy, SWOT and Corporate Finance Report, is a source...
MarketLine
August 2022
Price: USD 175.00
Turkey Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026 Summary Pharmaceuticals in Turkey industry profile provides top-line...
Catalog:
MarketLine
February 2023
Price: USD 350.00
REWE Group - Strategy, SWOT and Corporate Finance Report Summary REWE Group - Strategy, SWOT and Corporate Finance Report, is a source of...
Catalog:
MarketLine
May 2022
Price: USD 175.00
PHOENIX Group - Strategy, SWOT and Corporate Finance Report Summary PHOENIX Group - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
October 2022
Price: USD 175.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Breast Cancer Targeted Drug market will undergo major...
Catalog:
Arsta
July 2022
Price: USD 3,360.00
AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report Summary AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
November 2022
Price: USD 175.00
Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report Summary Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
December 2022
Price: USD 175.00
Merck KGaA - Strategy, SWOT and Corporate Finance Report Summary Merck KGaA - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
December 2022
Price: USD 175.00
Almirall S.A. - Strategy, SWOT and Corporate Finance Report Summary Almirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
December 2020
Price: USD 175.00
Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source...
Catalog:
MarketLine
December 2022
Price: USD 175.00
Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report Summary Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance...
MarketLine
November 2022
Price: USD 175.00
